Curanex Pharmaceuticals Prepares for IPO: A Botanical Biotech’s Transition to the Public Markets
Curanex Pharmaceuticals Inc, a preclinical-stage biotechnology company based in Jericho, New York, is preparing to transition from private development into the public domain. Specializing...
Hang Feng Technology Innovation Co., Ltd. (FOFO) Targets $5.5M NASDAQ IPO
Hang Feng Technology Innovation Co., Ltd. (NASDAQ: FOFO) has filed to raise $5.5 million through an initial public offering (IPO) on the NASDAQ. The...
Phaos Technology (Cayman) Holdings Ltd. Files for NYSE-American IPO
Phaos Technology (Cayman) Holdings Ltd., an advanced microscopy solutions provider, is preparing to go public on the NYSE-American under the ticker symbol POAS. The...
Curanex Pharmaceuticals Inc. (CURX) IPO: Botanical Drug Innovator Targets NASDAQ Capital Market
Curanex Pharmaceuticals Inc. (CURX) has officially filed for an Initial Public Offering (IPO) on the NASDAQ Capital Market, with a proposed price range of...
Yimutian Inc. IPO: NASDAQ Debut Sparks Investor Interest
Yimutian Inc. IPO (NASDAQ: YMT) is officially live after pricing on August 19, 2025, creating strong momentum among IPO investors. Listed on the NASDAQ...
